These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
54. Vascular response to vasodilator treatment in microalbuminuric diabetic kidney disease. Futrakul N; Futrakul P World J Nephrol; 2013 Nov; 2(4):125-8. PubMed ID: 24255895 [TBL] [Abstract][Full Text] [Related]
55. [The role of endoplasmic reticulum stress in the pregression of kidney disease]. Liu J; He YN Sheng Li Ke Xue Jin Zhan; 2010 Dec; 41(6):439-42. PubMed ID: 21416962 [No Abstract] [Full Text] [Related]
56. Role of the microvascular endothelium in progressive renal disease. Kang DH; Kanellis J; Hugo C; Truong L; Anderson S; Kerjaschki D; Schreiner GF; Johnson RJ J Am Soc Nephrol; 2002 Mar; 13(3):806-816. PubMed ID: 11856789 [TBL] [Abstract][Full Text] [Related]
57. Renovascular disease, microcirculation, and the progression of renal injury: role of angiogenesis. Chade AR Am J Physiol Regul Integr Comp Physiol; 2011 Apr; 300(4):R783-90. PubMed ID: 21307362 [TBL] [Abstract][Full Text] [Related]
58. Strategies to prevent progression of renal disease. Hall PM Cleve Clin J Med; 2001 Feb; 68(2):143-4, 146, 149-51, 152. PubMed ID: 11220456 [TBL] [Abstract][Full Text] [Related]
59. Microvascular disease and its role in the brain and cardiovascular system: a potential role for uric acid as a cardiorenal toxin. Kanbay M; Sánchez-Lozada LG; Franco M; Madero M; Solak Y; Rodriguez-Iturbe B; Covic A; Johnson RJ Nephrol Dial Transplant; 2011 Feb; 26(2):430-7. PubMed ID: 20935013 [TBL] [Abstract][Full Text] [Related]